ArticleInternational journal of molecular sciences2020

Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents.

Michael R Horsman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.